Discovery of Novel STING Inhibitors Based on the Structure of the Mouse STING Agonist DMXAA

The stimulator-of-interferon-gene (STING) protein is involved in innate immunity. The drug DMXAA (5,6-dimethylxanthenone-4-acetic acid) proved to be a potent murine-STING (mSTING) agonist but had little effect on human-STING (hSTING). In this paper, we draw upon the comparison of different crystal s...

Full description

Bibliographic Details
Main Authors: Jiajia Chang, Shi Hou, Xinlin Yan, Wei Li, Junhai Xiao
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/28/7/2906
_version_ 1797607430394216448
author Jiajia Chang
Shi Hou
Xinlin Yan
Wei Li
Junhai Xiao
author_facet Jiajia Chang
Shi Hou
Xinlin Yan
Wei Li
Junhai Xiao
author_sort Jiajia Chang
collection DOAJ
description The stimulator-of-interferon-gene (STING) protein is involved in innate immunity. The drug DMXAA (5,6-dimethylxanthenone-4-acetic acid) proved to be a potent murine-STING (mSTING) agonist but had little effect on human-STING (hSTING). In this paper, we draw upon the comparison of different crystal structures and protein-ligand interaction relationships analysis to venture the hypothesis that the drug design of DMXAA variants has the potential to convert STING agonists to inhibitors. Based on our previous discovery of two DMXAA analogs, <b>3</b> and <b>4</b> (both could bind to STING), we structurally optimized them and synthesized new derivatives, respectively. In binding assays, we found compounds <b>11</b> and <b>27</b> to represent STING binders that were superior to the original structures and discussed the structure-activity relationships. All target compounds were inactive in cellular assays for the screening of STING agonistic activity. Gratifyingly, we identified <b>11</b> and <b>27</b> as STING inhibitors with micromolar activity in both hSTING and mSTING pathways. In addition, <b>11</b> and <b>27</b> inhibited the induction of interferon and inflammatory cytokines activated by 2′3′-cGAMP without apparent cytotoxicity. These findings break the rigid thinking that DMXAA provides the structural basis specifically for STING agonists and open up more possibilities for developing novel STING agonists or inhibitors.
first_indexed 2024-03-11T05:30:58Z
format Article
id doaj.art-a642f340b6214e62817955b40fcc032b
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-11T05:30:58Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-a642f340b6214e62817955b40fcc032b2023-11-17T17:10:42ZengMDPI AGMolecules1420-30492023-03-01287290610.3390/molecules28072906Discovery of Novel STING Inhibitors Based on the Structure of the Mouse STING Agonist DMXAAJiajia Chang0Shi Hou1Xinlin Yan2Wei Li3Junhai Xiao4National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, ChinaNational Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, ChinaNational Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, ChinaNational Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, ChinaNational Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, ChinaThe stimulator-of-interferon-gene (STING) protein is involved in innate immunity. The drug DMXAA (5,6-dimethylxanthenone-4-acetic acid) proved to be a potent murine-STING (mSTING) agonist but had little effect on human-STING (hSTING). In this paper, we draw upon the comparison of different crystal structures and protein-ligand interaction relationships analysis to venture the hypothesis that the drug design of DMXAA variants has the potential to convert STING agonists to inhibitors. Based on our previous discovery of two DMXAA analogs, <b>3</b> and <b>4</b> (both could bind to STING), we structurally optimized them and synthesized new derivatives, respectively. In binding assays, we found compounds <b>11</b> and <b>27</b> to represent STING binders that were superior to the original structures and discussed the structure-activity relationships. All target compounds were inactive in cellular assays for the screening of STING agonistic activity. Gratifyingly, we identified <b>11</b> and <b>27</b> as STING inhibitors with micromolar activity in both hSTING and mSTING pathways. In addition, <b>11</b> and <b>27</b> inhibited the induction of interferon and inflammatory cytokines activated by 2′3′-cGAMP without apparent cytotoxicity. These findings break the rigid thinking that DMXAA provides the structural basis specifically for STING agonists and open up more possibilities for developing novel STING agonists or inhibitors.https://www.mdpi.com/1420-3049/28/7/2906STINGDMXAAspecies selectivitySTING agonistSTING inhibitor
spellingShingle Jiajia Chang
Shi Hou
Xinlin Yan
Wei Li
Junhai Xiao
Discovery of Novel STING Inhibitors Based on the Structure of the Mouse STING Agonist DMXAA
Molecules
STING
DMXAA
species selectivity
STING agonist
STING inhibitor
title Discovery of Novel STING Inhibitors Based on the Structure of the Mouse STING Agonist DMXAA
title_full Discovery of Novel STING Inhibitors Based on the Structure of the Mouse STING Agonist DMXAA
title_fullStr Discovery of Novel STING Inhibitors Based on the Structure of the Mouse STING Agonist DMXAA
title_full_unstemmed Discovery of Novel STING Inhibitors Based on the Structure of the Mouse STING Agonist DMXAA
title_short Discovery of Novel STING Inhibitors Based on the Structure of the Mouse STING Agonist DMXAA
title_sort discovery of novel sting inhibitors based on the structure of the mouse sting agonist dmxaa
topic STING
DMXAA
species selectivity
STING agonist
STING inhibitor
url https://www.mdpi.com/1420-3049/28/7/2906
work_keys_str_mv AT jiajiachang discoveryofnovelstinginhibitorsbasedonthestructureofthemousestingagonistdmxaa
AT shihou discoveryofnovelstinginhibitorsbasedonthestructureofthemousestingagonistdmxaa
AT xinlinyan discoveryofnovelstinginhibitorsbasedonthestructureofthemousestingagonistdmxaa
AT weili discoveryofnovelstinginhibitorsbasedonthestructureofthemousestingagonistdmxaa
AT junhaixiao discoveryofnovelstinginhibitorsbasedonthestructureofthemousestingagonistdmxaa